(Q43201354)

16 November 2017

European randomized study of prostate cancer screening: first-year results of the Finnish trial (English)

1 reference

prostate cancer screening

16 November 2017

0 references

1 reference

1 reference

2

Auvinen A

1 reference

16 November 2017

Määttänen L

1

1 reference

16 November 2017

Stenman UH

3

1 reference

16 November 2017

Rannikko S

4

1 reference

16 November 2017

Tammela T

5

1 reference

16 November 2017

Aro J

6

1 reference

16 November 2017

Juusela H

7

1 reference

16 November 2017

Hakama M

8

1 reference

16 November 2017

language of work or name

English

0 references

publication date

1 March 1999

1 reference

British Journal of Cancer

16 November 2017

1 reference

16 November 2017

79

1 reference

16 November 2017

7-8

1 reference

16 November 2017

1210-1214

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6690194

16 November 2017

0 references

cites work

The results of a five-year early prostate cancer detection intervention. Investigators of the American Cancer Society National Prostate Cancer Detection Project

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362232

Diagnosis of advanced or noncurable prostate cancer can be practically eliminated by prostate-specific antigen

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362232

Data quality and quality control of a population-based cancer registry. Experience in Finland

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362232

Report of the consensus workshop on screening and global strategy for prostate cancer

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362232

Screening for prostate cancer--necessity or nonsense?

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362232

Serum concentrations of prostate specific antigen and its complex with alpha 1-antichymotrypsin before diagnosis of prostate cancer

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362232

Breast cancer screening as public health policy in Finland

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362232

Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362232

Positive predictive value of screening mammography by age and family history of breast cancer

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362232

Observations on the doubling time of prostate cancer. The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362232

Longitudinal screening for prostate cancer with prostate-specific antigen

15 August 2018

1 reference

12 December 2020

Rise in prostatic cancer incidence associated with increased use of transurethral resection

1 reference

12 December 2020

A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer

1 reference

12 December 2020

Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin

1 reference

12 December 2020

Age-dependent growth rate of primary breast cancer

1 reference

12 December 2020

The definition and preoperative prediction of clinically insignificant prostate cancer

1 reference

12 December 2020

European randomized study of screening for prostate cancer--the Rotterdam pilot studies

1 reference

12 December 2020

Prospective evaluation plan for randomised trials of prostate cancer screening. The International Prostate Cancer Screening Trial Evaluation Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690194

7 January 2021

Latent carcinoma of prostate at autopsy in seven areas. The International Agency for Research on Cancer, Lyons, France

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690194

7 January 2021

Prostate-specific antigen, clinical use and staging: an overview

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690194

7 January 2021

Specificity of screening in United Kingdom trial of early detection of breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690194

7 January 2021

Identifiers

DOI

10.1038/SJ.BJC.6690194

1 reference

16 November 2017

1 reference

16 November 2017

PubMed publication ID

10098761

1 reference